Causes of the decline in AIDS deaths, United States, 1995-2002: Prevention, treatment or both?

International Journal of STD and AIDS

Volumn 16, Issue 12, 2005, Pages 777-781

  Holtgrave, David R ^a,b  

^a EMORY UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; Epidemiology; HIV; Prevention; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE CONTROL; EPIDEMIC; EPIDEMIOLOGICAL DATA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INCIDENCE; INFECTION PREVENTION; MORTALITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG RESISTANCE, VIRAL; HEALTH CARE SURVEYS; HIV-1; HUMANS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 30944440882     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646205774988109     Document Type: Review

References (14)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: US Cases of HIV and AIDS in the United States, 2002. Year-end edn. 2002;14, (Table 7)
2. Karon JM, Fleming PL, Steketee RW, DeCock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001;91:1060-8
3. Centers for Disease Control and Prevention. Update: AIDS - United States, 2000. MMWR 2002;51:592-5
4. Holtgrave DR. Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis. AIDS 2002;16:2347-9
5. Fleming PL, Ward JW, Karon JM, Hanson DL, DeCock KM. Declines in AIDS incidence and deaths in the USA. A signal change in the epidemic. AIDS 1998;12:S55-61
6. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: US HIV and AIDS cases reported through December 1993. Year-end edn. 1993;5 (Table 13)
7. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: US HIV and AIDS cases reported through December 2000. Year-end edn. 2001;13 (Table 33)
8. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991;253:37-42
9. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, DeCock KM. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health 2001;91:1019-24
10. Holtgrave DR, Pinkerton SD. Implications of economic evaluation for national HIV prevention policy makers. In Kaplan EH, Brookmeyer R, eds. Quantitative Evaluation of HIV Prevention Programs. New Haven, CT: Yale University Press, 2002;32-54
11. Holtgrave DR. Estimation of annual HIV transmission rates in the United States, 1978-2000. J Acquir Immune Defic Syndr 2004;35:89-92
12. Fleming PL, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States, 2000. Presented at the Ninth Conference on Retroviruses and Opportunistic Infections, 2002, Accessed 7 March 2003 online at [www.retroconference.org/2002/Abstract/13996.htm]
13. Brookmeyer R, Gail MH, eds. AIDS Epidemiology: A Quantitative Approach. New York: Oxford University Press, 1994;219
14. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Human Retrovirol 1997;16:54-62